VARIZIG (Aptevo BioTherapeutics LLC)


Welcome to the PulseAid listing for the VARIZIG drug offered from Aptevo BioTherapeutics LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aptevo BioTherapeutics LLC
NON-PROPRIETARY NAME: Varicella Zoster Immune Globulin (Human)
SUBSTANCE NAME: HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2016-07-01
END MARKETING DATE: 0000-00-00


VARIZIG HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVARIZIG from Aptevo BioTherapeutics LLC
LABELER NAME: Aptevo BioTherapeutics LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 125([iU]/1)
START MARKETING DATE: 2016-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70504-0126_097e23f2-3e24-41cd-b2f8-410b2db147b4
PRODUCT NDC: 70504-0126
APPLICATION NUMBER: BLA125430

Other HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aptevo BioTherapeutics LLCVARIZIG
Cangene BioPharmaVARIZIG